Ignite Creation Date:
2025-12-24 @ 5:00 PM
Ignite Modification Date:
2026-01-25 @ 3:32 AM
Study NCT ID:
NCT04523350
Status:
COMPLETED
Last Update Posted:
2024-12-16
First Post:
2020-08-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Instylla HES Hypervascular Tumor Pivotal Study
Sponsor:
Instylla, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
INY-P-20-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None